Sort
40,608 grants matching “prostate cancer”
Peptide-based conjugate for a water-insoluble drug treating advanced prostate cancer
$297,706Kun Cheng · University Of Missouri Kansas City · R01 · FY2018 · GM
Mechanisms of Metastasis in Experimental Prostate Cancer
$297,675Timothy C Thompson · Baylor College Of Medicine · R01 · FY2006 · CA
Selective Androgen Receptor Degraders (SARDs) as new therapeutics for spinal and bulbar muscular atrophy (SBMA)
$297,671Gunnar Joerg Floris Kaufmann · Oncternal Therapeutics, Inc. · R41 · FY2021 · NS
Polymers for Targeted Delivery of Angiogenic Inhibitors
$297,654Hamid Ghandehari · University Of Utah · R01 · FY2009 · EB
Reduced-Order Constrained Optimization for Rapid IMRT and VMAT Treatment Planning
$297,596Richard J Radke · Rensselaer Polytechnic Institute · R01 · FY2010 · CA
Genetic Analysis of a Prostate Tumor Suppressor Region
$297,587Paul C Marker · University Of Minnesota · R01 · FY2007 · AG
Development of Drugs That Target Prostate Cancer
$297,586William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Development of Angiogenesis Inhibitors
$297,586William Douglas Figg · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
P-2: The Effect of Rad on Androgen Receptor Expression and Activity in Prostate
$297,580Mark Garzotto · Fred Hutchinson Cancer Research Center · P50 · FY2010 · CA
Admin-Core-001
$297,550Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2023 · CA
Genetically Engineered Viruses for Prostate Cancer Therapy
$297,549Robert L Martuza · Massachusetts General Hospital · R01 · FY2013 · CA
VITAMIN D RECEPTOR AND REGULATION OF HORMONE RESPONSE
$297,547Stanford University · R01 · FY2001 · DK
The Molecular Profile of Prostate Tumors in African-American Men
$297,523Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Ligand-Specific Regulation of EGF Receptor Signaling
$297,501Nancy Louise Lill · Ohio State University · R01 · FY2009 · CA
Corepressor Regulation of Nuclear Receptor Action
$297,500Beth Israel Deaconess Medical Center · R01 · FY2005 · DK
Mechanistic Problems in Eukaryotic Gene Regulation
$297,460Olke C Uhlenbeck · Northwestern University · R01 · FY2011 · GM
Development of a Novel HCS Assay to Screen for Disruptors of AR-TIF2 Interactions
$297,452Paul A. Johnston · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · CA
Project 2: Developing an N-terminal inhibitor of the androgen receptor
$297,416Matthew B Rettig · University Of California Los Angeles · P50 · FY2019 · CA
Dissecting the Therapeutic Role of Pt3K aod AR Pathway Inhibition In Prostate Cancer
$297,413Pier Paolo Pandolfi · Sloan-Kettering Inst Can Research · P50 · FY2015 · CA
Project 2: Developing an N-terminal inhibitor of the androgen receptor
$297,413Matthew B Rettig · University Of California Los Angeles · P50 · FY2021 · CA
Small molecule antagonists of relaxin receptor
$297,403Alexander I. Agoulnik · Florida International University · U01 · FY2013 · CA
Health Care Partners in Cancer Prevention & Care of Aged
$297,398Eva Kahana · Case Western Reserve University · R01 · FY2007 · CA
Role of RNase L in the Biology of Prostate Cancer
$297,398Robert H. Silverman · Cleveland Clinic Lerner Com-Cwru · R01 · FY2007 · CA
T-bet and Tumor Immunity
$297,398Laurie H Glimcher · Harvard School Of Public Health · R01 · FY2009 · CA
Health Care Partners in Cancer Prevention & Care of Aged
$297,398Eva Kahana · Case Western Reserve University · R01 · FY2008 · CA